Robotic sentinel node biopsy for testicular cancer
Part of Cancer clinical trials.
This trial uses a robot and a special dye (ICG) to find and remove the first lymph node that might contain cancer cells in men with testicular cancer. It aims to reduce unnecessary lymph node removal while still detecting spread.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a testicular tumor confirmed by physical exam and ultrasound, with or without elevated tumor markers (AFP or β-HCG).
- No signs of cancer spread in CT scans of the chest and abdomen.
- You are 18 years or older.
- You can communicate with the study team and understand and sign the consent form.
- No prior scrotal or retroperitoneal surgery for a non-germ cell tumor, and no prior chemotherapy or radiation to the retroperitoneum.
- No allergy to ICG dye or iodine, no serious health conditions, and no psychiatric illness.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether removing affected lymph nodes with surgery (RPLND) works well alone for seminoma testicular cancer that has spread to nearby nodes but is still relatively small. It is for patients who have not had extensive chemo or radiation.
This study is testing a new way to map lymph nodes in children with solid tumors. It helps doctors understand how tumors spread to lymph nodes, which may guide treatment.
This trial looks at a minimally invasive surgery approach for people with colon adenocarcinoma that has not spread to lymph nodes or other organs. The team will use special mapping tests on the sentinel lymph node to better understand the cancer spread and help guide treatment decisions.
This trial tests using a green dye called ICG (indocyanine green) during breast cancer surgery to find the first lymph nodes (sentinel nodes) that cancer may have spread to. It aims to help doctors locate these nodes more accurately, and is for people with early-stage breast cancer that has not yet spread to the lymph nodes.
This trial tests if a special dye (indocyanine green) can find the first lymph nodes (sentinel nodes) during mastectomy. It may help improve staging for women with early breast cancer who need or choose mastectomy.
This trial tests a way for surgeons to find the first lymph nodes that testicular cancer might spread to, using a special camera and a dye. It could help doctors decide if you need extra treatment after surgery to remove the testicle.
Hear when a new Germ Cell Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.